Irish research identifies protein's role in prolonging cancer cell survival

Irish research published today has revealed a new target for future treatment of Hodgkin’s Lymphoma.

Irish research identifies protein's role in prolonging cancer cell survival

Irish research published today has revealed a new target for future treatment of Hodgkin’s Lymphoma.

The findings are the first indication that Bfl1 protein plays a crucial role in prolonging the survival of Hodgkin/Reed-Sternberg (HRS) cells, the malignant cell that is critical to tumour development.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited